Spots Global Cancer Trial Database for tremelimumab (cohort a dose)
Every month we try and update this database with for tremelimumab (cohort a dose) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab | NCT03638141 | Intermediate St... Hepatocellular ... | Durvalumab Tremelimumab (C... Tremelimumab (C... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |